미시간의 방광암 임상 시험
방광암 관련 연구 25개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.
미시간의 도시
- Grand Rapids연구 12개
- Detroit연구 11개
- Farmington Hills연구 6개
- Ann Arbor연구 6개
- Lansing연구 5개
- Wyoming연구 4개
- Canton연구 4개
- Warren연구 4개
- Dearborn연구 4개
- Clinton Township연구 4개
- Livonia연구 4개
- Waterford연구 3개
- Jackson연구 3개
- Kalamazoo연구 3개
- Troy연구 3개
공식 연구 텍스트(영어)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton
- Trinity Health Medical Center - Brighton, Brighton
- 외 32개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03866382Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health Medical Center - Brighton, Brighton
- Trinity Health Medical Center - Canton, Canton
- 외 8개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06770582A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
- Munson Medical Center ( Site 0812), Traverse City
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07419295A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Karmanos Cancer Institute, Detroit
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT05267626A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- START Midwest, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07217171ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 14. 업데이트됨 · NCT05059444A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT06465069Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
- Regents of the University of Michigan, Ann Arbor
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07144319Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Comprehensive Urology, Royal Oak
- Michigan Institute of Urology (Solaris), Troy
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06567743A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Profound Research -OMG - TriAtria Cancer Center, Farmington Hills
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06760819Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- 외 71개
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069The Vanguard Study: Testing a New Way to Screen for Cancer
- Henry Ford Cancer Institute-Downriver, Brownstown
- Henry Ford Health Center - Brownstown, Brownstown
- Henry Ford Health Center - Chesterfield, Chesterfield
- 외 13개
피험자 모집 중건강한 지원자 환영
45세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06995898Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Grand Rapids
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07129993FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Barbara Ann Karmanos Cancer Institute, Detroit
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT05614739Measuring Surgical Recovery After Radical Cystectomy
- Spectrum Health Medical Group, Grand Rapids
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT03193970Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- University of Michigan Rogel Cancer Center, Ann Arbor
- Bronson Battle Creek, Battle Creek
- University of Michigan - Brighton Center for Specialty Care, Brighton
- 외 22개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07097142A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT06242470A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT05592626LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Henry Ford Health System, Detroit
- Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT04752722Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
- Karmanos Cancer Institute, Detroit
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 7. 29. 업데이트됨 · NCT07106762A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- The Cancer & Hematology Centers, Big Rapids
- Karmanos Cancer Institute, Detroit
- Henry Ford Cancer - Detroit (Brigitte Harris Cancer Pavilion), Detroit
- 외 7개
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT04879329Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- START Midwest, Grand Rapids
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 2. 18. 업데이트됨 · NCT07030257SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774A Beta-only IL-2 ImmunoTherapY Study
- Karmanos Cancer Institute, Detroit
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2025. 7. 9. 업데이트됨 · NCT05086692ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.